| The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ... Cell 167 (5), 1145-1149, 2016 | 510 | 2016 |
| Survival analysis and causes of mortality in patients with lupus nephritis DYH Yap, CSO Tang, MKM Ma, MF Lam, TM Chan Nephrology Dialysis Transplantation 27 (8), 3248-3254, 2012 | 327 | 2012 |
| Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances DYH Yap, KN Lai BioMed Research International 2010, 2010 | 170 | 2010 |
| Overview of lupus nephritis management guidelines and perspective from A sia CC Mok, DYH Yap, SV Navarra, Z Liu, M Zhao, L Lu, T Takeuchi, ... Nephrology 19 (1), 11-20, 2014 | 137 | 2014 |
| The role of cytokines in the pathogenesis of systemic lupus erythematosus–from bench to bedside DYH Yap, KN Lai Nephrology 18 (4), 243-255, 2013 | 136 | 2013 |
| B cell abnormalities in systemic lupus erythematosus and lupus nephritis—role in pathogenesis and effect of immunosuppressive treatments DYH Yap, TM Chan International journal of molecular sciences 20 (24), 6231, 2019 | 119 | 2019 |
| Enhanced psychosocial support for caregiver burden for patients with chronic kidney failure choosing not to be treated by dialysis or transplantation: a pilot randomized … KY Chan, T Yip, DYH Yap, MK Sham, YC Wong, VWK Lau, CW Li, ... American Journal of Kidney Diseases 67 (4), 585-592, 2016 | 88 | 2016 |
| Pathogenesis of renal disease in systemic lupus erythematosus—the role of autoantibodies and lymphocytes subset abnormalities DYH Yap, KN Lai International journal of molecular sciences 16 (4), 7917-7931, 2015 | 87 | 2015 |
| Lupus nephritis in Asia: clinical features and management DYH Yap, TM Chan Kidney Diseases 1 (2), 100-109, 2015 | 85 | 2015 |
| Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome DYH Yap, X Yu, XMEI CHEN, F Lu, N Chen, XUEW LI, CS Tang, TM Chan Nephrology 17 (4), 352-357, 2012 | 85 | 2012 |
| Long-term outcome of renal transplant recipients with chronic hepatitis B infection—impact of antiviral treatments DYH Yap, CSO Tang, S Yung, BY Choy, MF Yuen, TM Chan Transplantation 90 (3), 325-330, 2010 | 79 | 2010 |
| Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF‐PH inhibitors DYH Yap, LP McMahon, CM Hao, N Hu, H Okada, Y Suzuki, SG Kim, ... Nephrology 26 (2), 105-118, 2021 | 70 | 2021 |
| Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis DYH Yap, MKM Ma, MMY Mok, CSO Tang, TM Chan Rheumatology 52 (3), 480-486, 2013 | 64 | 2013 |
| Longterm data on sirolimus treatment in patients with lupus nephritis DYH Yap, C Tang, GCW Chan, LPY Kwan, MKM Ma, MMY Mok, TM Chan The Journal of rheumatology 45 (12), 1663-1670, 2018 | 53 | 2018 |
| Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study SCW Tang, M Lin, S Tam, WS Au, MKM Ma, DYH Yap, YW Ho, KN Lai Nephrology Dialysis Transplantation 27 (2), 613-618, 2012 | 53 | 2012 |
| Proliferation signal inhibitors in the treatment of lupus nephritis: preliminary experience DYH Yap, MKM Ma, CSO Tang, TM Chan Nephrology 17 (8), 676-680, 2012 | 50 | 2012 |
| Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis KC Tse, CSO Tang, MF Lam, DYH Yap, TM Chan The Journal of Rheumatology 36 (1), 76-81, 2009 | 48 | 2009 |
| Long-term data on tacrolimus treatment in lupus nephritis DYH Yap, MKM Ma, MMY Mok, LPY Kwan, GCW Chan, TM Chan Rheumatology 53 (12), 2232-2237, 2014 | 47 | 2014 |
| Dyslipidaemia in patients with lupus nephritis YB Chong, DYH Yap, CS Tang, TM Chan Nephrology 16 (5), 511-517, 2011 | 47 | 2011 |
| Longterm data on disease flares in patients with proliferative lupus nephritis in recent years DYH Yap, C Tang, MKM Ma, MMY Mok, GCW Chan, LPY Kwan, TM Chan The Journal of Rheumatology 44 (9), 1375-1383, 2017 | 40 | 2017 |
